Arrowhead Pharmaceuticals, Inc. (ARWR)
82.85
+0.09
(+0.11%)
USD |
NASDAQ |
Sep 11, 16:00
82.79
-0.06
(-0.07%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Return Level : 82.85 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 82.85 |
| September 10, 2026 | 82.76 |
| September 09, 2026 | 82.63 |
| September 08, 2026 | 85.11 |
| September 04, 2026 | 86.34 |
| September 03, 2026 | 86.49 |
| September 02, 2026 | 85.37 |
| September 01, 2026 | 82.74 |
| August 31, 2026 | 82.39 |
| August 28, 2026 | 84.91 |
| August 27, 2026 | 88.59 |
| August 26, 2026 | 89.12 |
| August 25, 2026 | 88.88 |
| August 24, 2026 | 86.73 |
| August 21, 2026 | 87.11 |
| August 20, 2026 | 87.47 |
| August 19, 2026 | 89.41 |
| August 18, 2026 | 87.90 |
| August 17, 2026 | 88.70 |
| August 14, 2026 | 86.64 |
| August 13, 2026 | 85.59 |
| August 12, 2026 | 87.25 |
| August 11, 2026 | 89.24 |
| August 10, 2026 | 88.33 |
| August 07, 2026 | 87.65 |
| Date | Value |
|---|---|
| August 06, 2026 | 85.83 |
| August 05, 2026 | 86.91 |
| August 04, 2026 | 89.59 |
| August 03, 2026 | 86.01 |
| July 31, 2026 | 84.65 |
| July 30, 2026 | 87.32 |
| July 29, 2026 | 86.22 |
| July 28, 2026 | 85.78 |
| July 27, 2026 | 85.53 |
| July 24, 2026 | 85.60 |
| July 23, 2026 | 86.78 |
| July 22, 2026 | 88.70 |
| July 21, 2026 | 74.52 |
| July 20, 2026 | 71.65 |
| July 17, 2026 | 74.30 |
| July 16, 2026 | 71.38 |
| July 15, 2026 | 71.82 |
| July 14, 2026 | 71.91 |
| July 13, 2026 | 74.11 |
| July 10, 2026 | 76.40 |
| July 09, 2026 | 84.00 |
| July 08, 2026 | 85.74 |
| July 07, 2026 | 86.97 |
| July 06, 2026 | 86.55 |
| July 02, 2026 | 83.99 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Sarepta Therapeutics, Inc. | 20.45 |
| Revolution Medicines, Inc. | 203.77 |
| Moderna, Inc. | 143.97 |
| Intellia Therapeutics, Inc. | 11.74 |
| Denali Therapeutics, Inc. | 21.09 |